Related Experiment Video
Updated: Aug 14, 2026

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions
B Shafit-Zagardo1, Y Kress, M L Zhao
1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
Elucidation of the mechanisms involved in the regeneration of oligodendrocytes and remyelination is a central issue in multiple sclerosis (MS) research. We recently identified a novel alternatively spliced, developmentally regulated oligodendrocyte-specific protein designated microtubule-associated protein-2+13 [microtubule-associated protein-2 expressing exon 13 (MAP-2+13)]. MAP-2+13 is expressed in human fetal oligodendrocytes during process extension and myelination but is minimally expressed in normal mature CNS. To test the hypothesis that MAP-2+13 is reexpressed in regenerating oligodendrocytes in MS lesions, we examined the brains of MS patients for the expression of this protein. By immunocytochemistry using a series of monoclonal antibodies specific for MAP-2+13, we determined that MAP-2+13 expression was up-regulated in all 31 lesions from 10 different MS brains. MAP-2+13 was expressed in regenerating oligodendrocytes associated with demyelinated lesions, with the highest counts found in regions of extensive remyelination. By electron microscopy, MAP-2+13 was localized to oligodendrocytes engaged in remyelination, evident by their process extension and association with thinly myelinated (remyelinated) and demyelinated axons. These results suggest a hitherto unsuspected role for this microtubule-associated protein in oligodendrocyte function during development and myelin repair.
Insights
Microtubule-associated protein-2+13 (MAP-2+13) is reexpressed in regenerating oligodendrocytes within multiple sclerosis lesions. This protein plays a role in myelin repair and oligodendrocyte function during development.
Area of Science:
- Neuroscience
- Cell Biology
- Developmental Biology
Background:
- Multiple sclerosis (MS) research focuses on understanding oligodendrocyte regeneration and remyelination mechanisms.
- Oligodendrocytes are glial cells responsible for myelinating axons in the central nervous system (CNS).
- The protein microtubule-associated protein-2+13 (MAP-2+13) is developmentally regulated and specific to oligodendrocytes.
Purpose of the Study:
- To investigate the expression of MAP-2+13 in the context of MS lesions.
- To determine if MAP-2+13 is reexpressed in regenerating oligodendrocytes in MS.
- To elucidate the potential role of MAP-2+13 in myelin repair.
Main Methods:
- Immunocytochemistry using monoclonal antibodies specific for MAP-2+13.
- Examination of brain tissue from 10 multiple sclerosis patients with 31 lesions.
- Electron microscopy to localize MAP-2+13 within oligodendrocytes.
Main Results:
- MAP-2+13 expression was upregulated in all examined MS lesions.
- MAP-2+13 was found in regenerating oligodendrocytes associated with demyelinated areas.
- Highest MAP-2+13 expression correlated with regions of extensive remyelination.
- Electron microscopy confirmed MAP-2+13 localization in oligodendrocytes actively remyelinating axons.
Conclusions:
- MAP-2+13 is reexpressed in oligodendrocytes during myelin repair in MS lesions.
- This suggests a novel role for MAP-2+13 in oligodendrocyte function during CNS development and myelin regeneration.
- The findings provide new insights into the molecular mechanisms of remyelination in multiple sclerosis.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Microtubule Associated Motor Proteins
Assembly of Complex Microtubule Structures

